Cargando…

GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds

Recently reported HIV-1 capsid (CA) inhibitors GS-CA1 and GS-6207 (an analog of GS-CA1) are first-in-class compounds with long-acting potential. Reportedly, both compounds have greater potency than currently approved anti-HIV drugs. Due to the limited access to experimental data and the compounds th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Kamal, Gallazzi, Fabio, Hill, Kyle J., Burke, Donald H., Lange, Margaret J., Quinn, Thomas P., Neogi, Ujjwal, Sönnerborg, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613529/ https://www.ncbi.nlm.nih.gov/pubmed/31312185 http://dx.doi.org/10.3389/fmicb.2019.01227

Ejemplares similares

HIV Capsid Inhibitors Beyond PF74
por: McArthur, Carole, et al.
Publicado: (2019)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
por: Neogi, Ujjwal, et al.
Publicado: (2020)

Characterization of Inducible Transcription and Translation-Competent HIV-1 Using the RNAscope ISH Technology at a Single-Cell Resolution
por: Zhang, Wang, et al.
Publicado: (2018)

Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents
por: Spratt, Austin N., et al.
Publicado: (2021)

539. GS-CA2: A Novel, Potent, and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans
por: Zheng, Jim, et al.
Publicado: (2018)

Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy
por: Bai, Xiangning, et al.
Publicado: (2021)

Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy
por: Zhang, Wang, et al.
Publicado: (2017)

Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
por: Ray, Shilpa, et al.
Publicado: (2020)

Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades
por: Neogi, Ujjwal, et al.
Publicado: (2014)

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
por: Häggblom, Amanda, et al.
Publicado: (2017)

Long-Term Efficacy of First Line Antiretroviral Therapy in Indian HIV-1 Infected Patients: A Longitudinal Cohort Study
por: Neogi, Ujjwal, et al.
Publicado: (2013)

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden
por: Neogi, Ujjwal, et al.
Publicado: (2017)

Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
por: Saccon, Elisa, et al.
Publicado: (2021)

Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals
por: Neogi, Ujjwal, et al.
Publicado: (2013)

Structural Implications of Genotypic Variations in HIV-1 Integrase From Diverse Subtypes
por: Rogers, Leonard, et al.
Publicado: (2018)

Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy
por: Svärd, Jenny, et al.
Publicado: (2017)

Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers
por: Zhang, Wang, et al.
Publicado: (2017)

MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors
por: Aralaguppe, Shambhu G., et al.
Publicado: (2019)

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
por: Ambikan, Anoop T, et al.
Publicado: (2022)

Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
por: Sperk, Maike, et al.
Publicado: (2020)

Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
por: Sperk, Maike, et al.
Publicado: (2021)

The HLA class-II immunopeptidomes of AAV capsids proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2022)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing
por: Telele, Nigus Fikrie, et al.
Publicado: (2018)

A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort
por: Telele, Nigus Fikrie, et al.
Publicado: (2019)

Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers
por: Vesterbacka, Jan, et al.
Publicado: (2017)

Introducing ground cover management in pesticide emission modeling
por: Gentil‐Sergent, Céline, et al.
Publicado: (2021)

My iPhone: covers iPhone 3GS, 4, and 4S running iOS 5
por: Miser, Brad
Publicado: (2012)

Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2023)

Behind the scenes of GS: preventing and curing - the GS-SE group
por: CERN, GS-SE
Publicado: (2013)

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins
Publicado: (2023)

Expression, purification, and characterization of self-assembly virus-like particles of capsid protein L1 HPV 52 in Pichia pastoris GS115
por: Rosmeita, Chindy Nur, et al.
Publicado: (2023)

Alternative ground covers and strip-tilling in CBD hemp production
por: Osorio, Erika, et al.
Publicado: (2023)

Molecular Epidemiology of HIV-1 Subtypes in India: Origin and Evolutionary History of the Predominant Subtype C
por: Neogi, Ujjwal, et al.
Publicado: (2012)

The expanding HIV-1 epidemic aggravates therapeutics and vaccine development programs in India
por: Neogi, Ujjwal
Publicado: (2009)

High Throughput Determination of Plant Height, Ground Cover, and Above-Ground Biomass in Wheat with LiDAR
por: Jimenez-Berni, Jose A., et al.
Publicado: (2018)

Selection and identification of an RNA aptamer that specifically binds the HIV-1 capsid lattice and inhibits viral replication
por: Gruenke, Paige R, et al.
Publicado: (2022)

GS BBQ 2015
por: Rueda, Laura
Publicado: (2015)

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
por: Akusjärvi, Sara Svensson, et al.
Publicado: (2021)

Pion photoproduction and the "anomalous" transition $^{14}$N$_{g.s.}$ --> $^{14}$C$_{g.s.}$
por: Figureau, A, et al.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_dr7el0cvaob8ff4ko0m2bfbj08